Post-Operative Pain Management Companies

Jan 2024Medtronic Launched their Intellis™ Post-Operative Pain Management System, featuring an implantable spinal cord stimulator with Bluetooth connectivity for remote monitoring and personalized pain control adjustments. Partnered with pain management societies and healthcare providers to educate on the benefits of multimodal pain management approaches.

Johnson & Johnson Received FDA approval for Exparel® (bupivacaine liposome injectable suspension) for postoperative pain management in pediatric patients, expanding its application range and offering a safer alternative for children undergoing surgery. Focused on developing and integrating non-opioid analgesic options within their surgical care portfolio.

Abbott Laboratories Announced the expansion of their NerveXplore™ portfolio with the launch of a new single-shot nerve block catheter, offering longer-lasting pain relief and reducing the need for repeated injections. Collaborated with research institutions to develop novel nerve block techniques and optimize pain management protocols.

Baxter International Signed a strategic partnership with Vermis Technologies to commercialize their i-Flow® drug delivery system for regional anesthesia, allowing for targeted and continuous pain control during and after surgery. Emphasized their commitment to providing innovative and minimally invasive pain management solutions.

Actelion Pharmaceuticals Ltd, Presented positive Phase 3 data for their investigational drug, naloxone hydrochloride intranasal spray, for the treatment of postoperative opioid-induced respiratory depression, offering a potential rescue medication for opioid-related side effects. Focused on developing safer and more effective pain management options for the post-operative setting.

• Teva Pharmaceutical Industries Ltd.


• Eli Lilly


• Pfizer


• Johnson & Johnson


• Purdue Pharma


• Endo Pharmaceuticals Plc.


• Forest Laboratories Inc.


• GlaxoSmithKline Plc.